MTI Seminar Series Live Q&A. Mathew Garnett - Functional genomics approaches to guide cancer drug discovery - Shared screen with speaker view
Who can see your viewing activity?
Please do add questions here in the chat
In drug discovery, what are your thoughts about focusing on synthetic lethality approaches compared to targeting mutant proteins, as many can be undruggable, and how do you think your data can inform the identification of synthetic lethal targets?
Thanks Hakan, we’ll ask this in a few minutes
This is Andrej, can I clarify the question and also ask another one?
Hi Andrej, Ive unmuted you if you would like to clarify